You are currently viewing a new version of our website. To view the old version click .

Proton and Carbon Ion Therapy

Special Issue Information

Dear Colleagues,

Proton therapy was introduced in the 1940s and carbon-ion therapy was started in the 1990s. Recently the particle therapy of protons and carbon ions has spread to many countries around the world. Compared to conventional radiation treatment with X-rays, there are clinical reports that particle therapy is more effective against: 1) malignant tumors with less X-ray sensitivity; 2) tumors close to vital organs; and 3) large tumors.

In the upcoming Special Issue, we would like to discuss how particle therapy is employed for cancers that are difficult to treat with X-ray therapy, as well as possible future uses of this therapy and its current state of progress. It would also be beneficial to look into the efficacy of combining particle therapy with chemotherapy.

If we are able to clarify the strong points of ion beam radiotherapy in this special edition, we can expect progress on differentiating the uses of proton therapy and carbon-ion therapy from X-ray radiotherapy.

We also welcome advice from facilities that have experience with proton therapy and/or carbon-ion therapy to those medical institutions that are considering introducing it.

Dr. Yoshio Hishikawa
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694